Table 5: Importance of eligibility criteria to the principal investigators (n = 16) at each study centre when determining eligibility for of a patient for HCV treatment.
Eligibility criteria | Median* | Range |
---|---|---|
Age | 1.0 | 1.0–3.0 |
Sex | 1.0 | 1.0–3.0 |
HCV genotype | 3.5 | 1.0–5.0 |
Severity of fibrosis | 5.0 | 3.0–5.0 |
Past psychiatric comorbidity | 3.0 | 1.0–5.0 |
Current psychiatric comorbidity | 4.0 | 1.0–5.0 |
Current incarceration | 3.0 | 1.0–5.0 |
Past incarceration | 1.0 | 1.0–3.0 |
Past injection drug use | 1.0 | 1.0–3.0 |
Current injection drug use | 3.5 | 1.0–5.0 |
Past alcohol intake | 1.0 | 1.0–4.0 |
Current alcohol intake | 4.0 | 3.0–5.0 |
Past HCV treatment | 4.0 | 1.0–5.0 |
History of reinfection with HCV | 4.0 | 1.0–5.0 |
Potential for reinfection with HCV | 3.0 | 1.0–5.0 |
HCV = hepatitis C virus *Scores were ranked from 1 to 5, with 1 being less important and 5 being very important.